Has John Mak, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,115 in general payments to John Mak, MD across 457 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Mak, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Mak, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Mak, MD

Interventional Pain Medicine · Freehold, NJNPI 1417924168

Payments from drug & device makers

$12,115in general payments, 2019–2025

Across 457 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$2K
Vertos Medical, Inc.$1K
Scilex Pharmaceuticals Inc.$1K
MML US, Inc.$905
Collegium Pharmaceutical, Inc.$853
Saluda Medical Americas, Inc.$832
plus $6K from 40 others

What the payments were for

Travel & lodging$1,41912%
Food & beverage$10,68488%
Education$120%
Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	54	$1,640
Vertos Medical, Inc.	18	$1,006
Scilex Pharmaceuticals Inc.	69	$1,000
MML US, Inc.	6	$905
Collegium Pharmaceutical, Inc.	64	$853
Saluda Medical Americas, Inc.	16	$832
Abbott	34	$759
Globus Medical(2 entities)	7	$618
Nevro Corp.	12	$447
Averitas Pharma Inc.	22	$413
Medtronic(2 entities)	9	$395
Si-bone, Inc.	7	$387
Vertiflex, Inc.	7	$359
Biotronik NRO, Inc.	5	$290
Amgen	17	$227
Biodelivery Sciences International, Inc.	14	$195
GRT US Holding, Inc.	12	$186
Pfizer	14	$178
Spinal Elements, Inc.	2	$171
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	9	$127
Protega Pharmaceutials Inc	4	$111
SPR Therapeutics, Inc	3	$107
Almatica Pharma LLC	7	$94
Azurity Pharmaceuticals, Inc.	5	$85
Fidia Pharma USA Inc.	4	$70
Zimmer Biomet	2	$64
Stimwave Technologies Incorporated	1	$56
IBSA Pharma Inc.	4	$54
Johnson & Johnson	2	$52
Vertex	3	$49
MDD US Operations, LLC	3	$40
USWM, LLC	3	$40
Nalu Medical, Inc.	2	$38
Pacira Pharmaceuticals Incorporated	2	$32
Ambu Inc.	1	$31
Assertio Therapeutics, Inc.	2	$28
Vertical Pharmaceuticals, LLC	2	$27
Spinal Simplicity, LLC	1	$24
Valinor Pharma, LLC	1	$19
Bioventus LLC	1	$18
Daiichi Sankyo Inc.	1	$18
Virtus Pharmaceuticals LLC	1	$18
Tersera Therapeutics LLC	1	$15
Zyla Life Sciences, Inc.	1	$14
Pacira Therapeutics, Inc.	1	$11
Teva Pharmaceuticals USA, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,115 in reported general payments places this provider in the 85th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$291,897

Medicare patients

530

Services billed

3,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	167	$2,147
Pregabalin	84	$1,524
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	86	$1,088
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	62	$771
Tramadol Hcl ErTramadol Hcl	15	$672
Tramadol Hcl	116	$468
Methylprednisolone	66	$403
Oxycodone Hcl	26	$395
Tizanidine Hcl	33	$336
Celecoxib	23	$331
Meloxicam	83	$262
Cyclobenzaprine Hcl	40	$213
Acetaminophen-CodeineAcetaminophen With Codeine	13	$86
Diazepam	14	$18

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Freehold

Ali ValimahomedHolmdel$863K
Youssef JosephsonWest Deptford$582K
Saurabh DangEdgewater$271K
Gabriele JasperBrick$126K
Matthew LippChatham$67K
Didier DemesminSomerset$61K
Steve AydinFranklin Lakes$22K
Kieran SlevinHainesport$21K
John CoccaroToms River$17K
Dinash YanamadulaLawrenceville$16K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →